CVT recently announced a profit warning saying 2004 NPAT would be same as 2003, due to higher NZD and delayed product launch. From memory, revenues had grown ~20%p.a. last 5-7 years, but that was on back of first overseas expansion - would it slow? Agree with k1w1 too about capital requirements - ROE was poor: couple of rights issue pre listing, big raising earlier this year, and a DRP. My conclusion was that it had reasonable growth potential but it was largely in the price. i.e. repeat of 2003 NPAT of 1.15m = eps of ~9cps. Pe of 25. Fisher Funds can have them!